The research was supervised by CEPID BRAINN´s researchers, Dr. Rickson Mesquita and Dr. Gabriela Castellano. Check out the report from HC Unicamp.
World Health Organization’s (WHO) Technical Advisory Group on Genomics (TAG-G), chaired by researcher Iscia Lopes-Cendes, publishes article in Nature Medicine.
Article from Agência FAPESP interviews researcher from CEPID BRAINN and details the need for awareness, professional training, and investment in genomics.
Global Study Identifies Markers for the Five Clinical Stages of Parkinson’s Disease
Research, which included the participation of BRAINN, analyzed data from over 2,500 individuals with Parkinson’s and developed metrics for each clinical stage of the disease.
World’s largest epilepsy study reveals ‘genetic architecture’ and points to new therapies
Considered the largest genetic study of epilepsy in the world, paper published in Nature Genetics reveals alterations in DNA that signal a greater risk for the brain disorder.
Can the lingering effects of a mild case of COVID-19 change your brain?
Study finds brain changes in people with anxiety, depression symptoms.
Anxiety, Your Brain, and Long COVID: What the Research Says
WebMD article details the effects of long COVID on mental health and interviews BRAINN researcher (and COVID specialist) dr. Clarissa Yasuda.
BRAINN at NatureResearch: “A new model for brain research”
At the Brazilian Research Institute for Neuroscience and Neurotechnology (BRAINN), researchers combine disciplines to find new ways to address the age-old conditions of epilepsies and strokes. Read more…
Devices help predict seizures and treat patients with epilepsy
Agência FAPESP interviews the Australian researcher Mark Cook on implantable devices aimed at controlling epilepsy.
Read more…
BRAINN Congress highlights new technologies and discusses public health
Article published in the Unicamp Portal highlights the technological and scientific advances discussed at the 6th BRAINN Congress.
Read more…
SUS to incorporate Exoma sequencing to diagnose intellectual disability
Decision to adopt the exam was guided by a technical-scientific opinion prepared by a doctorate from FCM-Unicamp, working with researchers from CEPID BRAINN.
Read more…
CEPID BRAINN 
Português do Brasil